Cipher Pharmaceuticals (TSE:CPH) Stock Price Crosses Above 50-Day Moving Average – Should You Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR)’s stock price crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$14.92 and traded as high as C$15.19. Cipher Pharmaceuticals shares last traded at C$15.01, with a volume of 28,914 shares traded.

Cipher Pharmaceuticals Stock Performance

The company has a market capitalization of C$380.80 million, a P/E ratio of 22.40 and a beta of 1.31. The company has a debt-to-equity ratio of 41.22, a quick ratio of 2.67 and a current ratio of 2.00. The business’s fifty day simple moving average is C$14.92 and its 200-day simple moving average is C$14.92.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.